Neuropathic pain: proposal of a mechanism-based treatment

Abstract

Neuropathic pain, defined by the International Association for the Study of Pain as “pain caused by a lesion or disease of the somatosensory system”, has an estimated prevalence of 7–9.2% in the general population and is associated with poorer health-related quality of life than other types of pain. Diagnosis can be improved by the use of diagnostic algorithms, but treatment remains rather unsatisfactory, with only 30–40% of patients achieving an acceptable response. Some authors have suggested that the poor results in the treatment of neuropathic pain may be related to the different mechanisms present in each patient and have tried to correlate them with clinical characteristics in order to evaluate possible targeted treatments. This approach has been used in some studies evaluating the response to specific pharmacotherapies in clusters of patients, with encouraging results but still limited applicability to clinical practice. In this narrative review, we attempt to analyse the literature suggesting possible pathogenetic mechanisms manifested along the nociceptive pathway due to a lesion or disease of the nervous system; aware of the limitations of exploring such a wide field, we look for conditions that could be targeted by the available pharmacological or interventional treatment options. Functional changes may occur in the nociceptive system from the periphery to the cerebral cortex, in particular in the nociceptive terminals, along the first-order neuron and the dorsal root ganglion, at the first synapses, or at supraspinal levels. Clinical assessment is the first step in the study of anatomical and functional changes; the diagnostic hypothesis should be confirmed, if possible, by instrumental studies or diagnostic blocks or procedures to guide an individualised therapeutic algorithm from less to more invasive treatments.

Keywords

Neuropathic pain / neuropathic pain diagnoses / neuropathic pain mechanisms / mechanism-based treatment

References

[1] Jensen TS,Baron R,Haanpää M,Kalso E,Loeser JD,Rice ASC,et al.A new definition of neuropathic pain.Pain.2011;152:2204-5.

[2] Raja SN,Carr DB,Cohen M,Finnerup NB,Flor H,Gibson S,et al.The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises.Pain.2020;161:1976-82.

[3] Barke A,Korwisi B,Jakob R,Konstanjsek N,Rief W,Treede RD.Classification of chronic pain for the International Classification of Diseases (ICD-11): results of the 2017 international World Health Organization field testing.Pain.2022;163:e310-8.

[4] Bouhassira D.Neuropathic pain: Definition, assessment and epidemiology.Rev Neurol (Paris).2019;175:16-25.

[5] Baskozos G,Hébert HL,Pascal MM,Themistocleous AC,Macfarlane GJ,Wynick D,et al.Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank.Pain Rep.2023;8:e1066.

[6] Treede R,Jensen TS,Campbell JN,Cruccu G,Dostrovsky JO,Griffin JW,et al.Neuropathic pain: Redefinition and a grading system for clinical and research purposes.Neurology.2008;70:1630-5.

[7] Finnerup NB,Haroutounian S,Kamerman P,Baron R,Bennett DLH,Bouhassira D,et al.Neuropathic pain: an updated grading system for research and clinical practice.Pain.2016;157:1599-606.

[8] Moradi A,Ebrahimzadeh MH,Jupiter JB.Radial Tunnel Syndrome, Diagnostic and Treatment Dilemma.Arch Bone Jt Surg.2015;3:156-62.

[9] Attal N,Bouhassira D,Colvin L.Advances and challenges in neuropathic pain: a narrative review and future directions.British Journal of Anaesthesia.2023;131:79-92.

[10] Finnerup NB,Attal N,Haroutounian S,McNicol E,Baron R,Dworkin RH,et al.Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.Lancet Neurol.2015;14:162-73.

[11] Moisset X,Bouhassira D,Avez Couturier J,Alchaar H,Conradi S,Delmotte MH,et al.Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.Rev Neurol (Paris).2020;176:325-52.

[12] Baron R,Förster M,Binder A.Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach.Lancet Neurol.2012;11:999-1005.

[13] Baron R,Maier C,Attal N,Binder A,Bouhassira D,Cruccu G,et al.German Neuropathic Pain Research Network (DFNS);EUROPAIN;NEUROPAIN consortia.Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles.Pain.2017;158:261-72.

[14] Bouhassira D,Attal N.Personalized treatment of neuropathic pain: Where are we now?Eur J Pain.2023;27:1084-98.

[15] Schott GD.The cartography of pain: The evolving contribution of pain maps.Eur J Pain.2010;14:784-91.

[16] Bouhassira D,Attal N,Alchaar H,Boureau F,Brochet B,Bruxelle J,et al.Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).Pain.2005;114:29-36.

[17] Bennett M.The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.Pain.2001;92:147-57.

[18] Freynhagen R,Baron R,Gockel U,Tölle TR.painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.Curr Med Res Opin.2006;22:1911-20.

[19] Galer BS,Jensen MP.Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale.Neurology.1997;48:332-8.

[20] Baron R,Dickenson AH,Calvo M,Dib-Hajj SD,Bennett DL.Maximizing treatment efficacy through patient stratification in neuropathic pain trials.Nat Rev Neurol.2023;19:53-64.

[21] Reimer M,Forstenpointner J,Hartmann A,Otto JC,Vollert J,Gierthmühlen J,et al.Sensory bedside testing: a simple stratification approach for sensory phenotyping.Pain Rep.2020;5:e820.

[22] De Stefano G,Truini A.An overview of diagnosis and assessment methods for neuropathic pain.Presse Med.2024;53:104234.

[23] Louie D,Earp B,Blazar P.Long-Term Outcomes of Carpal Tunnel Release: A Critical Review of the Literature.Hand (N Y).2012;7:242-6.

[24] Seretny M,Currie GL,Sena ES,Ramnarine S,Grant R,MacLeod MR,et al.Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.Pain.2014;155:2461-70.

[25] Ye F,Lyu FJ,Wang H,Zheng Z.The involvement of immune system in intervertebral disc herniation and degeneration.JOR Spine.2022;5:e1196.

[26] Cho HK,Cho YW,Kim EH,Sluijter ME,Hwang SJ,Ahn SH.Changes in pain behavior and glial activation in the spinal dorsal horn after pulsed radiofrequency current administration to the dorsal root ganglion in a rat model of lumbar disc herniation: laboratory investigation.J Neurosurg Spine.2013;19:256-63.

[27] Demartini L,Abbott DM,Bonezzi C,Natoli S.Radiofrequency stimulation of the dorsal root ganglion as a diagnostic tool for radicular pain syndromes: six representative cases.J Anesth Analg Crit Care.2024;4:60.

[28] Garcia-Larrea L.The pathophysiology of neuropathic pain: critical review of models and mechanisms.Pain.2014:453-75.

[29] Terayama R,Uchibe K.Reorganization of synaptic inputs to spinal dorsal horn neurons in neuropathic pain.Int J Neurosci.2022;132:1210-6.

[30] Garcia-Larrea L,Magnin M.Pathophysiology of neuropathic pain: review of experimental models and proposed mechanisms.Presse Med.2008;37:315-40. French.

[31] Martinoli C,Bianchi S,Derchi LE.Ultrasonography of peripheral nerves.Semin Ultrasound CT MR.2000;21:205-13.

[32] Fields HL,Rowbotham M,Baron R.Postherpetic Neuralgia: Irritable Nociceptors and Deafferentation.Neurobiology of Disease.1998;5:209-27.

[33] Basso L,Altier C.Transient Receptor Potential Channels in neuropathic pain.Curr Opin Pharmacol.2017;32:9-15.

[34] Devor M.Sodium Channels and Mechanisms of Neuropathic Pain.J Pain.2006;7:S3-12.

[35] Hameed S.Na_v1.7 and Na_v1.8: Role in the pathophysiology of pain.Mol Pain.2019;15:1744806919858801.

[36] Bennett DL,Woods CG.Painful and painless channelopathies.Lancet Neurol.2014;13:587-99.

[37] Ma RSY,Kayani K,Whyte-Oshodi D,Whyte-Oshodi A,Nachiappan N,Gnanarajah S,et al.Voltage gated sodium channels as therapeutic targets for chronic pain.J Pain Res.2019;12:2709-22.

[38] Ellis A,Bennett DL.Neuroinflammation and the generation of neuropathic pain.Br J Anaesth.2013;111:26-37.

[39] Obara I,Telezhkin V,Alrashdi I,Chazot PL.Histamine, histamine receptors, and neuropathic pain relief.Br J Pharmacol.2020;177:580-99.

[40] Groninger H,Schisler RE.Topical Capsaicin for Neuropathic Pain #255.J Palliat Med.2012;15:946-7.

[41] Arora V,Campbell JN,Chung MK.Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain.Pharmacol Ther.2021;220:107743.

[42] Sendel M,Dunst A,Forstenpointner J,Hüllemann P,Baron R.Capsaicin treatment in neuropathic pain: axon reflex vasodilatation after 4 weeks correlates with pain reduction.Pain.2023;164:534-42.

[43] Demant DT,Lund K,Finnerup NB,Vollert J,Maier C,Segerdahl MS,et al.Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study.Pain.2015;156:2234-44.

[44] Demant DT,Lund K,Vollert J,Maier C,Segerdahl M,Finnerup NB,et al.The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study.Pain.2014;155:2263-73.

[45] Carmland ME,Kreutzfeldt MD,Holbech JV,Brask-Thomsen PK,Krøigård T,Hansen PN,et al.The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial.Eur J Pain.2024;28:105-19.

[46] Russo MA,Baron R,Dickenson AH,Kern KU,Santarelli DM.Ambroxol for neuropathic pain: hiding in plain sight?Pain.2023;164:3-13.

[47] Osteen JD,Immani S,Tapley TL,Indersmitten T,Hurst NW,Healey T,et al.Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective Na_v1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain.Pain Ther.2025;14:655-74.

[48] Dekhne A,Goklani HD,Doshi N,Baskara Salian R,Gandhi SK,Patel P.Effectiveness of Botulinum Toxin in the Treatment of Neuropathic Pain: A Literature Review.Cureus.2023;15:e46848.

[49] Allen CB,Williamson TK,Norwood SM,Gupta A.Do Electrical Stimulation Devices Reduce Pain and Improve Function? —A Comparative Review.Pain Ther.2023;12:1339-54.

[50] Fried K,Govrin-Lippmann R,Rosenthal F,Ellisman MH,Devor M.Ultrastructure of afferent axon endings in a neuroma.J Neurocytol.1991;20:682-701.

[51] Matzner O,Devor M.Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+ channels.J Neurophysiol.1994;72:349-59.

[52] Lai J,Hunter JC,Porreca F.The role of voltage-gated sodium channels in neuropathic pain.Curr Opin Neurobiol.2003;13:291-7.

[53] Amir R,Kocsis JD,Devor M.Multiple Interacting Sites of Ectopic Spike Electrogenesis in Primary Sensory Neurons.J Neurosci.2005;25:2576-85.

[54] Wu G,Ringkamp M,Hartke TV,Murinson BB,Campbell JN,Griffin JW,et al.Early Onset of Spontaneous Activity in Uninjured C-Fiber Nociceptors after Injury to Neighboring Nerve Fibers.J Neurosci.2001;21:RC140.

[55] Rappaport HZ,Devor M.Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion.Pain.1994;56:127-38.

[56] Hwang CD,Hoftiezer YAJ,Raasveld FV,Gomez-Eslava B,van der Heijden EPA,Jayakar S,et al.Biology and pathophysiology of symptomatic neuromas.Pain.2024;165:550-64.

[57] Michaelis M,Vogel C,Blenk KH,Jänig W.Algesics excite axotomised afferent nerve fibres within the first hours following nerve transection in rats.Pain.1997;72:347-54.

[58] Moalem G,Grafe P,Tracey DJ.Chemical mediators enhance the excitability of unmyelinated sensory axons in normal and injured peripheral nerve of the rat.Neuroscience.2005;134:1399-411.

[59] Blenk KH,Michaelis M,Vogel C,Jänig W.Thermosensitivity of acutely axotomized sensory nerve fibers.J Neurophysiol.1996;76:743-52.

[60] Lyon C,Syfert J,Nashelsky J.Clinical Inquiry: Do corticosteroid injections improve carpal tunnel syndrome symptoms?J Fam Pract.2016;65:125-8.

[61] Padua L,Coraci D,Erra C,Pazzaglia C,Paolasso I,Loreti C,et al.Carpal tunnel syndrome: clinical features, diagnosis, and management.Lancet Neurol.2016;15:1273-84.

[62] Ducic I,Yoon J,Eberlin KR.Treatment of Neuroma-induced Chronic Pain and Management of Nerve Defects with Processed Nerve Allografts.Plast Reconstr Surg Glob Open.2019;7:e2467.

[63] Horishita T,Yanagihara N,Ueno S,Okura D,Horishita R,Minami T,et al.Antidepressants inhibit Na_v1.3, Na_v1.7, and Na_v1.8 neuronal voltage-gated sodium channels more potently than Na_v1.2 and Na_v1.6 channels expressed in Xenopus oocytes.Naunyn Schmiedebergs Arch Pharmacol.2017;390:1255-70.

[64] Nardone A,Schieppati M.Influences of transcutaneous electrical stimulation of cutaneous and mixed nerves on subcortical and cortical somatosensory evoked potentials.Electroencephalogr Clin Neurophysiol.1989;74:24-35.

[65] Da Cunha PHM,Lapa JDDS,Hosomi K,de Andrade DC.Neuromodulation for neuropathic pain.Int Rev Neurobiol.2024;179:471-502.

[66] Biel E,Aroke EN,Maye J,Zhang SJ.The applications of cryoneurolysis for acute and chronic pain management.Pain Pract.2023;23:204-15.

[67] Vallejo R,Tilley DM,Williams J,Labak S,Aliaga L,Benyamin RM.Pulsed radiofrequency modulates pain regulatory gene expression along the nociceptive pathway.Pain Physician.2013;16:E601-13.

[68] Krames ES.The Role of the Dorsal Root Ganglion in the Development of Neuropathic Pain.Pain Med.2014;15:1669-85.

[69] Howe JF,Loeser JD,Calvin WH.Mechanosensitivity of dorsal root ganglia and chronically injured axons: A physiological basis for the radicular pain of nerve root compression.Pain.1977;3:25-41.

[70] Waxman SG,Cummins TR,Dib-Hajj SD,Black JA.Voltage-gated sodium channels and the molecular pathogenesis of pain: a review.J Rehabil Res Dev.2000;37:517-28.

[71] Akopian AN,Sivilotti L,Wood JN.A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons.Nature.1996;379:257-62.

[72] Dib-Hajj SD,Fjell J,Cummins TR,Zheng Z,Fried K,LaMotte R,et al.Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain.Pain.1999;83:591-600.

[73] Sapunar D,Kostic S,Banozic A,Puljak L.Dorsal root ganglion - a potential new therapeutic target for neuropathic pain.J Pain Res.2012;5:31-8.

[74] McLachlan EM,Jänig W,Devor M,Michaelis M.Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia.Nature.1993;363:543-6.

[75] Hanani M.Satellite glial cells in sensory ganglia: from form to function.Brain Res Brain Res Rev.2005;48:457-76.

[76] Obata K,Yamanaka H,Fukuoka T,Yi D,Tokunaga A,Hashimoto N,et al.Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats.Pain.2003;101:65-77.

[77] Yatziv SL,Devor M.Suppression of neuropathic pain by selective silencing of dorsal root ganglion ectopia using nonblocking concentrations of lidocaine.Pain.2019;160:2105-14.

[78] Gemes G,Koopmeiners A,Rigaud M,Lirk P,Sapunar D,Bangaru ML,et al.Failure of action potential propagation in sensory neurons: mechanisms and loss of afferent filtering in C-type units after painful nerve injury.J Physiol.2013;591:1111-31.

[79] Jayapaula P,Rajana TT,Kaliyaperumal G.Efficacy of Transforaminal epidural steroid injection in patients with lumbar radiculopathy.Interdisciplinary Neurosurgery.2020;21:100706.

[80] Li JY,Xie W,Strong JA,Guo QL,Zhang JM.Mechanical Hypersensitivity, Sympathetic Sprouting, and Glial Activation Are Attenuated by Local Injection of Corticosteroid Near the Lumbar Ganglion in a Rat Model of Neuropathic Pain.Reg Anesth Pain Med.2011;36:56-62.

[81] Berta T,Qadri Y,Tan PH,Ji RR.Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain.Expert Opin Ther Targets.2017;21:695-703.

[82] Park S,Park JH,Jang JN,Choi SI,Song Y,Kim YU,et al.Pulsed radiofrequency of lumbar dorsal root ganglion for lumbar radicular pain: A systematic review and meta-analysis.Pain Pract.2024;24:772-85.

[83] Wang H,Zhang D,Wang S,Wang H,Nie H.Comparison of the efficacy of pulsed radiofrequency in treating acute herpetic neuralgia and postherpetic neuralgia in the thoracic segment.Front Neurol.2024;15:1425796.

[84] D’Souza RS,Kubrova E,Her YF,Barman RA,Smith BJ,Alvarez GM,et al.Dorsal Root Ganglion Stimulation for Lower Extremity Neuropathic Pain Syndromes: An Evidence-Based Literature Review.Adv Ther.2022;39:4440-73.

[85] Finnerup NB,Kuner R,Jensen TS.Neuropathic Pain: From Mechanisms to Treatment.Physiol Rev.2021;101:259-301.

[86] Woolf CJ,Shortland P,Coggeshall RE.Peripheral nerve injury triggers central sprouting of myelinated afferents.Nature.1992;355:75-8.

[87] Coull JA,Beggs S,Boudreau D,Boivin D,Tsuda M,Inoue K,et al.BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain.Nature.2005;438:1017-21.

[88] Okamoto M,Baba H,Goldstein PA,Higashi H,Shimoji K,Yoshimura M.Functional reorganization of sensory pathways in the rat spinal dorsal horn following peripheral nerve injury.J Physiol.2001;532:241-50.

[89] Rahman W,D’Mello R,Dickenson AH.Peripheral Nerve Injury–Induced Changes in Spinal α₂-Adrenoceptor–Mediated Modulation of Mechanically Evoked Dorsal Horn Neuronal Responses.J Pain.2008;9:350-9.

[90] Bee LA,Dickenson AH.Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin.Pain.2008;140:209-23.

[91] Vera-Portocarrero LP,Zhang ET,Ossipov MH,Xie JY,King T,Lai J,et al.Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization.Neuroscience.2006;140:1311-20.

[92] Kohno T,Ji RR,Ito N,Allchorne AJ,Befort K,Karchewski LA,et al.Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord.Pain.2005;117:77-87.

[93] West SJ,Bannister K,Dickenson AH,Bennett DL.Circuitry and plasticity of the dorsal horn--Toward a better understanding of neuropathic pain.Neuroscience.2015;300:254-75.

[94] Loeser JD.Definition, aetiology and neurological assessment of pain originating in the nervous system following deafferentation.Pain.1981;11:S81.

[95] Wynn Parry CB.Brachial plexus injuries.Br J Hosp Med.1984;32:130-2, 134.

[96] Saarto T,Wiffen PJ.Antidepressants for neuropathic pain.Cochrane Database Syst Rev.2007;2007:CD005454.

[97] Thouaye M,Yalcin I.Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons.Pharmacol Ther.2023;251:108546.

[98] Benyamin R,Trescot AM,Datta S,Buenaventura R,Adlaka R,Sehgal N,et al.Opioid complications and side effects.Pain Physician.2008;11:S105-20.

[99] Caylor J,Reddy R,Yin S,Cui C,Huang M,Huang C,et al.Spinal cord stimulation in chronic pain: evidence and theory for mechanisms of action.Bioelectron Med.2019;5:12.

[100] Fontaine D.Spinal cord stimulation for neuropathic pain.Rev Neurol (Paris).2021;177:838-42.

[101] Garcia-Larrea L,Peyron R.Pain matrices and neuropathic pain matrices: a review.Pain.2013;154:S29-43.

[102] Widerström-Noga E,Loeser JD,Jensen TS,Finnerup NB.AAPT Diagnostic Criteria for Central Neuropathic Pain.J Pain.2017;18:1417-26.

[103] Oliveira RAA,Baptista AF,Sá KN,Barbosa LM,Nascimento OJMd,Listik C,et al.Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology.Arq Neuropsiquiatr.2020;78:741-52.

[104] Meacham K,Shepherd A,Mohapatra DP,Haroutounian S.Neuropathic Pain: Central vs. Peripheral Mechanisms.Curr Pain Headache Rep.2017;21:28.

[105] Wood PB.Role of central dopamine in pain and analgesia.Expert Rev Neurother.2008;8:781-97.

[106] Dong XW,Jia Y,Lu SX,Zhou X,Cohen-Williams M,Hodgson R,et al.The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain.Psychopharmacology (Berl).2008;195:559-68.

[107] Seidel S,Aigner M,Wildner B,Sycha T,Pablik E.Antipsychotics for the treatment of neuropathic pain in adults.Cochrane Database Syst Rev.2018; 2018:CD012916.

[108] Bai Y,Ma JH,Yu Y,Wang ZW.Effect of Cognitive-Behavioral Therapy or Mindfulness Therapy on Pain and Quality of Life in Patients with Diabetic Neuropathy: A Systematic Review and Meta-Analysis.Pain Manag Nurs.2022;23:861-70.